The pharma industry is well known for its consideration towards understanding of potential therapeutic vaccines. Vaccines help in treating a disease or condition by stimulating or strengthening an immune response. On the basis of product, the global therapeutic vaccines market is segmented into addiction vaccines, autoimmune disease vaccines, infectious disease vaccines and neurological disease vaccines.
Therapeutic vaccines have significantly developed and lay a significant impact to treat prostate cancer, breast cancer, lung cancer and also Alzheimer’s disease. Chronic diseases and chronic stress are now cured by therapeutic vaccines and the variety of condition it causes. Similar products are also in development to treat multiple conditions under a single vaccine. For instance, immunotherapies include passive or immunomodulatory strategies against cancers whereas active immunotherapies enhance the stability of patient’s immune system to recognize tumor-associated antigens and remove malignant cells.
Passive immunotherapy involves administration of exogenously produced components such as lymphocytes or antibodies. Immunomodulatory agents are not specified for particular antigens but improve general immune responsiveness and are targeted to augment anticancer immune responses. Therapeutic vaccines are specially designed for HIV positive people who have a weak immune system. The vaccines provide energy to the affected tissue and help the immunity to grow stronger.
On a commercial scale, rise in cancer and HIV patients regionally, the therapeutic vaccines are developed accordingly. With the rise in chronic diseases, the market for therapeutic market rises too. Hence, the global therapeutic vaccines market is anticipated to grow at a higher CAGR during the forecast period.
The key driving factors responsible for the growth of therapeutic vaccines market includes growth in prevalence of chronic diseases such as HIV, Cancer, heart and neuro diseases. Additionally, rise in increase for efficient treatment is now emphasized for effective treatment across the world. Moreover, companies have now begun to research on various diseases such as breast cancer, lung cancer and Alzheimer. However, lengthy processes for approval and developers of therapeutic vaccines dealing with non-existent reimbursement policies for vaccines are a major factor hindering the global market. On the basis of technologies, the global therapeutic vaccines market is segmented into autologous vaccines, allogenic vaccines.
On the basis of geographic segmentation, the global therapeutic vaccines market spans North America, Asia-Pacific, Middle-East, Europe and Africa. North America leads the global market owing to advanced healthcare infrastructure and also increased funding in R&D activities is likely to boost the market growth in the upcoming years. Europe and APAC regions are now witnessing a significant rise in demand for therapeutic vaccines due to growing prevalence of several diseases.
APAC regions are likely to benefit from growing awareness among consumers with regards to therapeutic vaccines and their advantages in the upcoming years. European market growth is mainly due to technological developments of products in the upcoming years. The key players in the global therapeutic vaccines market include Antigenics, Affiris, Celldex Therapeutics, Bavarian Nordic, Biovest International, Argos Therapeutics, Cel-Sci, Celtic Pharma, Curevac, and Cytos Biotechnology.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Therapeutic Vaccines in these regions, from 2012 to 2022 (forecast), covering
• North America
• Southeast Asia
Global Therapeutic Vaccines market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
• Northeast Biotherapeutics
• Vaccinogen Inc
• CIMAB S.A
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
• Peptide Therapeutic Vaccine
• Cell Therapeutic Vaccine
• Nucleic Acid Therapeutic Vaccine
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Therapeutic Vaccines for each application, including
• Hepatitis B
• Herpes Simplex Virus
Research Support Specialist, USA